SS
OACCW

Steve Schonfeld’s Oaktree Acquisition Corp III Life Sciences Warrant OACCW Stock Holding History

Steve Schonfeld’s Portfolio OACCW Stock Details OACCW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.5K Sell
16,500
-35,130
-68% -$29.5K ﹤0.01% 2469
2026
Q1 		$36.8K Sell
51,630
-2,106
-4% -$1.65K ﹤0.01% 2007
2025
Q4 		$44.3K Sell
53,736
-5,184
-9% -$4.33K ﹤0.01% 1887
2025
Q3 		$44.2K Sell
58,920
-30,534
-34% -$24.7K ﹤0.01% 2071
2025
Q2 		$78.3K Buy
89,454
+66,243
+285% +$51.1K ﹤0.01% 1856
2025
Q1 		$17.4K Buy
+23,211
New +$17.6K ﹤0.01% 2109

Other funds holding OACCW

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
DAM
Decagon Asset Management London, United Kingdom $525M AUM 50.51% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return
BGGS
Boussard & Gavaudan Gestion SAS Paris, France $1.99B AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
LA
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Steve Schonfeld's OACCW Position: Q2 2026 in Review

Steve Schonfeld reduced its Oaktree Acquisition Corp III Life Sciences Warrant (OACCW) stake by 68% in Q2 2026, selling an estimated $29.5K and leaving 16,500 shares worth $15.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2469.

Steve Schonfeld first reported a position in OACCW in Q1 2025 and has held it in 6 quarters since. The position peaked at $78.3K in Q2 2025. 27 funds tracked by Wall St. Rank hold OACCW as of Q2 2026.

  • Steve Schonfeld held 16,500 shares of Oaktree Acquisition Corp III Life Sciences Warrant worth $15.5K as of Q2 2026.
  • Steve Schonfeld sold 35,130 Oaktree Acquisition Corp III Life Sciences Warrant shares in Q2 2026, an estimated $29.5K.
  • Oaktree Acquisition Corp III Life Sciences Warrant made up ﹤0.01% of Steve Schonfeld's portfolio in Q2 2026, its #2469 holding.
  • Steve Schonfeld first reported a position in Oaktree Acquisition Corp III Life Sciences Warrant in Q1 2025 and has held it in 6 quarters since.
  • Steve Schonfeld's Oaktree Acquisition Corp III Life Sciences Warrant position peaked at $78.3K in Q2 2025.
  • 27 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences Warrant as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.